Disease Models & Mechanisms · 2018 · 33 citations · 37 references
Life SciencesGeneticsMolecular BiologyGene ExpressionGene TherapyGenome EditingCrispr-based EngineeringDisease ModelingNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersRedox Metabolism In DiseaseAnimal Disease ModelsCrispr-cas9 Genome EditingCrispr-cas9 KnockoutCrispr-cas9 Knockout ModelsGene-targeted TherapyInducible Gene TherapyIron-sulfur Cluster BiogenesisLabile Iron Pool
The neurodegenerative disease Friedreich's ataxia is caused by lower than normal levels of frataxin, an important protein involved in iron sulphur cluster biogenesis. An important step in designing strategies to treat this disease is to understand whether increasing the frataxin levels by gene therapy would be tout-court beneficial or detrimental since previous studies, mostly based on animal models, have reported conflicting results. Here, we have exploited an inducible model, which we developed using the CRISPR/Cas9 methodology, to study the effects of frataxin overexpression in human cells and follow how the system recovers after overexpression. Using novel tools which range from high throughput microscopy to in cell infrared, we prove that overexpression of the frataxin gene affects the cellular metabolism. It also lead to a significant increase of oxidative stress and labile iron pool levels. These cellular alterations are similar to those observed when the gene is partially silenced, as it occurs in Friedreich's ataxia's patients. Our data suggest that the levels of frataxin must be tightly regulated and fine-tuned, any imbalance leading to oxidative stress and toxicity.
37
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Agnès Rötig, Pascale de Lonlay, Dominique Chrétien et al. · Nature Genetics · 1997 · 991 citations
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein‐Bey‐Abina, Julia Hauer, Capucine Pïcard et al. · New England Journal of Medicine · 2010 · 624 citations · Full text
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
David Herman, Kai Jenssen, Ryan Burnett et al. · Nature Chemical Biology · 2006 · 435 citations · Full text